Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity

British Journal of Cancer

Volumn 85, Issue 6, 2001, Pages 902-908

  Galmarini, C M ^a   Falette, N ^a   Tabone, E ^b   Levrat, C ^c   Britten, R ^d   Voorzanger Rousselot, N ^a   Roesch Gateau, O ^c   Vanier Viornery, A ^a   Puisieux, A ^a   Dumontet, C ^a  

^a INSERM   (France)

^b CENTRE LÉON BÉRARD   (France)

^c UNIVERSITÉ LYON 1   (France)

^d CROSS CANCER INSTITUTE   (Canada)

Author keywords

Apoptosis; Breast cancer cell lines; Drug resistance; p53; Paclitaxel

Indexed keywords

CASPASE 3; CASPASE 9; CYCLINE; DOCETAXEL; DOXORUBICIN; FLAVOPIRIDOL; LIPOCORTIN 5; MITOMYCIN C; NAVELBINE; PACLITAXEL; PROTEIN P21; PROTEIN P53; RAF PROTEIN; TUBULIN; VINBLASTINE; VINDESINE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER RESISTANCE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GENE INACTIVATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; NORTHERN BLOTTING; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0035860132     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.2017     Document Type: Article

References (37)

1. Characterisation of human cyclin G1 and G2: DNA damage inducible genes
2. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway
3. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization
4. Apoptosis, p53, and tumor cell sensitivity to anticancer agents
5. Requirement for p53 and p21 to sustain G2 arrest after DNA damage
6. Flavopiridol induces apoptosis in chronic lymphocytic leukemia cells via activation of caspase-3 without evidence of bcl-2 modulation or dependence on functional p53
7. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
8. A p53-dependent mouse spindle checkpoint
9. p53 activity and chemotherapy
10. Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol)
11. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents
12. Cross-talk between the tumor suppressor p53 and the Ras/Raf/MAPK cascade
13. Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells
14. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents
15. Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells
16. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis
17. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations
18. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death
19. p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest
20. Cancer. p53, guardian of the genome
21. Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line
22. Interaction of vinca alkaloids with tubulin: A comparison of vinblastine, vincristine, and vinorelbine
23. p53 status and the efficacy of cancer therapy in vivo
24. Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts
25. Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoreduplication in human cancer cells
26. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules
27. Pulse treatment of interphasic HeLa cells with nanomolar doses of docetaxel affects centrosome organization and leads to catastrophic exit of mitosis
28. High Raf-1 kinase activity protects human tumor cells against paclitaxel-induced cytotoxicity
29. The spindle assembly checkpoint
30. Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells
31. Identification of a minimal transforming domain of p53: Negative dominance through abrogation of sequence-specific DNA binding
32. Differential Taxol-dependent arrest of transformed and nontransformed cells in the G1 phase of the cell cycle, and specific-related mortality of transformed cells
33. Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay
34. Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cells
35. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis
36. p53 and chemosensitivity
37. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked